Want to join the conversation?
$AGN said 3% of Allergan U.S. branded sales are distributed through unaffiliated specialty pharmacies, the majority of which are unique specialty products. $AGN said its Anda distribution segment is a traditional pharmaceutical wholesaler with no specialty pharmacy capabilities or licensing.
$BABA seems to be on a roll! But increasing its yearly sales outlook from 48% to 54% seems over-expectation from the company's part, doesn't it?
$JNJ down 2% in pre-market trading. Earnings beat expectations, but sales disappointed. Johnson is cautious on its outlook. How it will perform in the future?